Results 11 to 20 of about 5,787 (193)
The MIR34B/C genomic region contains multiple potential regulators of multiciliogenesis
FEBS Letters, Volume 597, Issue 12, Page 1623-1637, June 2023., 2023 Using single‐cell RNA‐seq and super‐resolution microscopy from several multiciliogenesis models, we show that BTG4, LAYN, and HOATZ, three proximal genes of the MIR34B/C locus, are expressed in precursors and mature multiciliated cells (MCCs). This graphical abstract illustrates the localization of Layilin/LAYN and HOATZ in motile cilia of MCCs.
Amélie Cavard +15 more
wiley +1 more source
Cancer Medicine, Volume 12, Issue 11, Page 12749-12764, June 2023., 2023 Abstract Background Healthy behaviors, that is, engaging in regular physical activities, maintaining a healthy diet, limiting alcohol consumption, and avoiding tobacco and drug use, decrease the risk of developing late adverse health conditions in childhood cancer survivors.
Eline Bouwman +20 more
wiley +1 more source
Who is vulnerable to energy poverty in the Global North, and what is their experience?
WIREs Energy and Environment, Volume 11, Issue 6, November/December 2022., 2022 The image depicts a single‐parent, mother‐led family from an ethnic minority background watching TV in bed in the evenings to keep warm without the heating on, to represent some of the experiences and backgrounds of the energy poor. Note: Artwork by Mary Tallontire @marytallontire Abstract Energy poverty is a fast rising government agenda in the Global
Lucie Middlemiss
wiley +1 more source
Journal of Bone and Mineral Research, Volume 37, Issue 8, Page 1511-1519, August 2022., 2022 ABSTRACT Systemic inflammation is associated with reduced bone mineral density and may be influenced by pro‐inflammatory diets. We undertook an observational analysis of associations between late pregnancy energy‐adjusted dietary inflammatory index (E‐DII) scores and offspring bone outcomes in childhood.
Stephen J Woolford +13 more
wiley +1 more source
Human Mutation, Volume 43, Issue 6, Page 717-733, June 2022., 2022 The RD‐Connect Genome‐Phenome Analysis Platform (GPAP) is a scalable and interoperable online system which facilitates the collation, analysis, interpretation and sharing of integrated genome‐phenome datasets, with a particular focus on RD case diagnosis and novel gene discovery.
Steven Laurie +51 more
wiley +1 more source
Chemistry – A European Journal, Volume 28, Issue 21, April 12, 2022., 2022 Signalling in the red, when antibiotics are bound to novel dual functional donor‐acceptor‐donor‐substituted benzoxadiazole probes with unprecedented large Stokes shifts, containing a benzoylthiourea receptor for carboxylate binding and a tertiary amine‐appended methacrylate linker for covalent matrix incorporation.
Virginia Valderrey +2 more
wiley +1 more source
Magnetic Resonance in Medicine, Volume 87, Issue 2, Page 686-701, February 2022., 2022 Purpose We compare the performance of three commonly used MRI‐guided attenuation correction approaches in torso PET/MRI, namely segmentation‐, atlas‐, and deep learning‐based algorithms. Methods Twenty‐five co‐registered torso 18F‐FDG PET/CT and PET/MR images were enrolled.
Hossein Arabi, Habib Zaidi
wiley +1 more source
Liver International, Volume 41, Issue 11, Page 2659-2670, November 2021., 2021 Abstract Background and Aims Peroxisome proliferator‐activated receptor (PPAR)‐γ agonists decrease hepatic/visceral fat (VF) and improve necroinflammation despite subcutaneous (SC) fat weight‐gain. Understanding the impact of changes in VF, VF‐to‐SC fat distribution (VF/SC) and adiponectin (ADPN) levels in relation to histological improvement after ...
Amalia Gastaldelli +10 more
wiley +1 more source
The Use of Rifaximin in Patients With Cirrhosis
Hepatology, Volume 74, Issue 3, Page 1660-1673, September 2021., 2021 Rifaximin is an oral nonsystemic antibiotic with minimal gastrointestinal absorption and broad‐spectrum antibacterial activity covering both gram‐positive and gram‐negative organisms. Rifaximin is currently used worldwide in patients with cirrhosis for preventing recurrent HE because its efficacy and safety have been proven by large randomized clinical
Paolo Caraceni +46 more
wiley +1 more source
Recovery of Bone Marrow Function in VEXAS Syndrome‐potential Role for Romiplostim
, 2023 HemaSphere, Volume 7, Issue 8, August 2023.
Adam Al‐Hakim +12 more
wiley +1 more source